Your browser doesn't support javascript.
loading
Effect of Renal Impairment on the Pharmacokinetics of a Single Oral Dose of Danuglipron in Participants With Type 2 Diabetes.
Fediuk, Daryl J; Gorman, Donal N; Stoddard, Stephanie-An; Zhang, Yizhong; Ogden, Adam G; Winton, Jennifer A; Saxena, Aditi R.
Afiliação
  • Fediuk DJ; Clinical Pharmacology and Bioanalytics, Pfizer Worldwide Research, Development and Medical, Groton, CT, USA.
  • Gorman DN; Global Biometrics and Data Management, Pfizer Global Product Development, Cambridge, UK.
  • Stoddard SA; Early Clinical Development, Clinical Sciences, Pfizer Worldwide Research, Development and Medical, Cambridge, MA, USA.
  • Zhang Y; Clinical Pharmacology and Bioanalytics, Pfizer Worldwide Research, Development and Medical, Groton, CT, USA.
  • Ogden AG; Clinical Pharmacology and Bioanalytics, Pfizer Worldwide Research, Development and Medical, Groton, CT, USA.
  • Winton JA; Clinical Pharmacology and Bioanalytics, Pfizer Worldwide Research, Development and Medical, Groton, CT, USA.
  • Saxena AR; Internal Medicine Research Unit, Pfizer Worldwide Research, Development and Medical, Cambridge, MA, USA.
J Clin Pharmacol ; 64(4): 449-460, 2024 Apr.
Article em En | MEDLINE | ID: mdl-37840155
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Insuficiência Renal Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Insuficiência Renal Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article